Trump & Sanders’ reimportation proposals a risk, AmerisourceBergen – in-Pharma Technologist

” “How a wholesaler could potentially procure drugs, whether they’re in Canada, Europe and get those back to the US and get those into the supply channel efficiently and effectively I think is quite cumbersome,” said CFO Tim Guttman. “It’s not efficient and there are risks.” VP Barbara Brungess added despite the impracticalities and legal hurdles to overturn, the primary concern is safety.”

Read the full article:  Source: Trump & Sanders’ reimportation proposals a risk, AmerisourceBergen – in-Pharma Technologist.com


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Designated Representative and Exemptee Training

Training Certification Class for Designated Representative and Exemptee license applicants